Glycogen for Smyd3-antisense oligonucleotide delivery and enhanced liver cancer gene therapy.

Bai N, Huang Y, Shen J, Peng Y, Zhang H, Hou D

DOI: 10.1039/d5ra06597f
Published: 2025 Nov 27
Container: RSC advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d5ra06597f,
  title = {Glycogen for Smyd3-antisense oligonucleotide delivery and enhanced liver cancer gene therapy.},
  author = {Bai N and Huang Y and Shen J and Peng Y and Zhang H and Hou D},
  year = {2025},
  journal = {RSC advances},
  doi = {10.1039/d5ra06597f},
  url = {https://doi.org/10.1039/d5ra06597f}
}

RIS

TY  - JOUR
TI  - Glycogen for Smyd3-antisense oligonucleotide delivery and enhanced liver cancer gene therapy.
AU  - Bai N
AU  - Huang Y
AU  - Shen J
AU  - Peng Y
AU  - Zhang H
AU  - Hou D
PY  - 2025
JO  - RSC advances
DO  - 10.1039/d5ra06597f
UR  - https://doi.org/10.1039/d5ra06597f
ER  -

APA

N, B., Y, H., J, S., Y, P., H, Z., & D, H. (2025). Glycogen for Smyd3-antisense oligonucleotide delivery and enhanced liver cancer gene therapy.. RSC advances. https://doi.org/10.1039/d5ra06597f

Source records

pubmed · retrieved 2026-09-25T05:17:34.975Z